Target intelligence / Profile preview

DNA polymerase delta subunit 2 (POLD2)

Target
POLD2
Molecular classification
Enzyme, DNA polymerase accessory subunit, Component of DNA polymerase delta complex
01

Overview

DNA polymerase delta subunit 2 (POLD2) is the 50-kDa accessory subunit of the DNA polymerase delta complex, which is essential for high-fidelity DNA replication and repair. As a non-catalytic component, POLD2 stabilizes the holoenzyme, promotes processivity through interaction with the proliferating cell nuclear antigen (PCNA), and is involved in both lagging and leading strand synthesis. It is also a component of the DNA polymerase zeta complex, supporting translesion synthesis and various DNA repair pathways, including nucleotide excision repair. Mutations or altered expression of POLD2 are linked with increased genomic instability and cancers. Small molecule inhibitors such as cytarabine target DNA synthesis, exploiting POLD2 function for therapeutic benefit, particularly in oncology[1][3][5][6][7].

Other names
DNA polymerase delta 2, accessory subunitPOLD2DNA polymerase delta subunit p50Pol delta B subunit (p50)polymerase (DNA directed), delta 2, accessory subunitpolymerase (DNA directed), delta 2, regulatory subunit 50kDaDNA polymerase δ 2, accessory subunitp50po1D2
02

Mechanism of action

Inhibition of DNA synthesis by nucleoside analog incorporation, leading to selective toxicity in replicating cells

03

Biological functions

DNA replicationDNA repairGenome fidelityLagging strand synthesisNucleotide excision repairTranslesion synthesisRegulation of DNA synthesis processivity
04

Disease associations

Cancer (notably implicated as a potential biomarker in ovarian carcinoma)Dyskeratosis congenita, autosomal dominant 6X-linked sideroblastic anemia with ataxiaGenome instability disorders
05

Safety considerations

Inhibition or genetic disruption may impair normal DNA replication and repair, leading to cytotoxicity in dividing tissues
06

Interacting drugs

Cytarabine (ara-C)

1 more in the full profile.

07

Biomarkers

Expression level may serve as a marker in some cancers (e.g., ovarian carcinoma)

Beyond the preview

Go deeper on DNA polymerase delta subunit 2 (POLD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase delta subunit 2 (POLD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call